|
|
|||||||||||||
|
|
||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original articles |
1 Kidz First Middlemore Hospital, New Zealand
2 University of Auckland, New Zealand
3 National Women's Hospital, New Zealand
* To whom correspondence should be addressed. E-mail: j.harding{at}auckland.ac.nz.
Accepted 19 August 2005
| Abstract |
|---|
Objective:To determine if exposure to more than one course of antenatal glucocorticoids is associated with changes in infant blood pressure and myocardial wall thickness in the first month after birth.
Design:Prospective cohort study
Setting:Tertiary Neonatal Intensive Care Unit
Participants:Mothers who were eligible for but declined to enter a randomised trial of repeated doses of antenatal glucocorticoids (ACTORDS) i.e. who had a singleton, twin or triplet pregnancy at <32 weeks gestation, had received an initial course of glucocorticoids seven or more days previously and were considered to be at continued risk of preterm birth.
Main outcome measures:Blood pressure daily for the first week then weekly until 4 weeks of age. End diastolic interventricular septal and left ventricular posterior wall thickness (EDIVS and EDLVPW) at 48-72h after birth.
Results:Thirty seven women were enrolled and delivered 50 infants. Thirty mothers (39 infants) were exposed to one course of glucocorticoids and 7 mothers (11 infants) to more than one course. Blood pressures were higher in the first week after birth in infants exposed to multiple courses of glucocorticoids, and in infants with a latency between last exposure and delivery of less than 7 days. Systolic blood pressure on day 1 was >2SD above published normal ranges in 67% of babies exposed to multiple courses and 24% of babies exposed to a single course of glucocorticoids (P=0.04). There was no difference between groups in thickness of the EDIVS or EDLVPW. However 44/50 (88%) babies had EDIVS and 49/50 (98%) babies had EDLVPW thickness >2 SD above the expected mean for birthweight and gestation. EDIVS but not EDLVPW thickness increased with increasing latency (mean 0.02mm per day, p = 0.03).
Conclusion:Future randomised trials should assess the longterm effects of exposure to antenatal glucocorticoids, and particularly multiple courses, on the cardiovascular status of the infant.
Keywords: blood pressure, corticosteroids, premature, cardiac hypertrophy
This article has been cited by other articles:
![]() |
W. B. de Vries, R. Karemaker, N. F. Mooy, J. L. M. Strengers, H. Kemperman, W. Baerts, S. Veen, G. H. A. Visser, C. J. Heijnen, and F. van Bel Cardiovascular Follow-up at School Age After Perinatal Glucocorticoid Exposure in Prematurely Born Children: Perinatal Glucocorticoid Therapy and Cardiovascular Follow-up Arch Pediatr Adolesc Med, August 1, 2008; 162(8): 738 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Gatford, J. A. Owens, S. Li, T. J. M. Moss, J. P. Newnham, J. R. G. Challis, and D. M. Sloboda Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E170 - E178. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Crowther, L. W. Doyle, R. R. Haslam, J. E. Hiller, J. E. Harding, J. S. Robinson, and the ACTORDS Study Group Outcomes at 2 Years of Age after Repeat Doses of Antenatal Corticosteroids N. Engl. J. Med., September 20, 2007; 357(12): 1179 - 1189. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |